Isolated creatine kinase-MB rise with normal cardiac troponins: A strange occurrence with difficult interpretation

Journal of Cardiovascular Medicine

Volumn 12, Issue 10, 2011, Pages 736-740

  Ricci, Fabrizio ^a   De Caterina, Raffaele ^a  

^a UNIVERSITY OF CHIETI   (Italy)

Author keywords

biomarkers; cardiac enzymes; myocardial infarction; myocardial necrosis

Indexed keywords

CREATINE KINASE MB; MYOGLOBIN; TROPONIN;

ACUTE CORONARY SYNDROME; ADULT; BLOOD CLOT LYSIS; CASE REPORT; ELECTROCARDIOGRAM; HEART INFARCTION; HUMAN; MALE; PHYSICAL EXAMINATION; PROGNOSIS; REVIEW; THORAX PAIN;

ACUTE CORONARY SYNDROME; ADULT; ANGINA PECTORIS; BIOLOGICAL MARKERS; CARDIOVASCULAR AGENTS; CORONARY ANGIOGRAPHY; CREATINE KINASE, MB FORM; DRUG THERAPY, COMBINATION; ELECTROCARDIOGRAPHY; HUMANS; MALE; PREDICTIVE VALUE OF TESTS; TIME FACTORS; TREATMENT OUTCOME; TROPONIN; UP-REGULATION;

EID: 80052641108     PISSN: 15582027     EISSN: 15582035     Source Type: Journal    
DOI: 10.2459/JCM.0b013e32834ae66c     Document Type: Review

References (42)

1. Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization task force on standardization of clinical nomenclature. Circulation 1979; 59:607-609.
2. Thygesen K, Alpert JS, White HD. Universal definition of myocardial infarction. Eur Heart J 2007; 28:2525-2538. (Pubitemid 47616190)
3. Ammann P, Fehr T, Minder EI, Gunter C, Bertel O. Elevation of troponin I in sepsis and septic shock. Intensive Care Med 2001; 27:965-969. (Pubitemid 32662476)
4. Zellweger MJ, Schaer BA, Cron TA, Pfisterer ME, Osswald S. Elevated troponin levels in absence of coronary artery disease after supraventricular tachycardia. Swiss Med Wkly 2003; 133:439-441. (Pubitemid 37247851)
5. Jaffe AS, Ritter C, Meltzer V, Harter H, Roberts R. Unmasking artifactual increases in creatine kinase isoenzymes in patients with renal failure. J Lab Clin Med 1984; 104:193-202. (Pubitemid 14055134)
6. Hochberg MC, Koppes GM, Edwards CQ, Barnes HV, Arnett FC Jr. Hypothyroidism presenting as a polymyositis-like syndrome. Report of two cases. Arthritis Rheum 1976; 19:1363-1366.
7. Panteghini M. Acute coronary syndrome: biochemical strategies in the troponin era. Chest 2002; 122:1428-1435. (Pubitemid 35339563)
8. Wu AH, Jaffe AS, Apple FS, et al. National Academy of Clinical Biochemistry laboratory medicine practice guidelines: use of cardiac troponin and B-type natriuretic peptide or N-terminal proB-type natriuretic peptide for etiologies other than acute coronary syndromes and heart failure. Clin Chem 2007; 53:2086-2096. (Pubitemid 350197291)
9. Saiki A, Iwase M, Takeichi Y, et al. Diversity of the elevation of serum cardiac troponin I levels in patients during their first visit to the emergency room. Circ J 2007; 71:1458-1462. (Pubitemid 47378450)
10. Apple FS, Smith SW, Pearce LA, Murakami MM. Assessment of the multiple-biomarker approach for diagnosis of myocardial infarction in patients presenting with symptoms suggestive of acute coronary syndrome. Clin Chem 2009; 55:93-100.
11. McCann CJ, Glover BM, Menown IB, et al. Novel biomarkers in early diagnosis of acute myocardial infarction compared with cardiac troponin T. Eur Heart J 2008; 29:2843-2850.
12. Jaffe AS. Chasing troponin: how low can you go if you can see the rise? J Am Coll Cardiol 2006; 48:1763-1764.
13. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation 2004; 110:e82-e292.
14. Saenger AK, Jaffe AS. Requiem for a heavyweight: the demise of creatine kinase-MB. Circulation 2008; 118:2200-2206.
15. Jaffe AS, Garfinkel BT, Ritter CS, Sobel BE. Plasma MB creatine kinase after vigorous exercise in professional athletes. Am J Cardiol 1984; 53:856-858.
16. Wu AH, Apple FS, Gibler WB, Jesse RL, Warshaw MM, Valdes R Jr. National Academy of Clinical Biochemistry Standards of Laboratory Practice: recommendations for the use of cardiac markers in coronary artery diseases. Clin Chem 1999; 45:1104-1121. (Pubitemid 29340557)
17. Yee KC, Mukherjee D, Smith DE, et al. Prognostic significance of an elevated creatine kinase in the absence of an elevated troponin I during an acute coronary syndrome. Am J Cardiol 2003; 92:1442-1444. (Pubitemid 37532568)
18. Newby LK, Roe MT, Chen AY, et al. Frequency and clinical implications of discordant creatine kinase-MB and troponin measurements in acute coronary syndromes. J Am Coll Cardiol 2006; 47:312-318. (Pubitemid 43065483)
19. Storrow AB, Lindsell CJ, Han JH, et al. Discordant cardiac biomarkers: frequency and outcomes in emergency department patients with chest pain. Ann Emerg Med 2006; 48:660-665. (Pubitemid 44738144)
20. Katus HA, Remppis A, Scheffold T, Diederich KW, Kuebler W. Intracellular compartmentation of cardiac troponin T and its release kinetics in patients with reperfused and nonreperfused myocardial infarction. Am J Cardiol 1991; 67:1360-1367.
21. Beranek JT. MCC-135 diminishes the egress of CK-MB but not of troponin-I from cardiomyocytes during reperfusion [author reply]. Ann Thorac Surg 2005; 79:1095. (Pubitemid 40288803)
22. Wu AH. Increased troponin in patients with sepsis and septic shock: myocardial necrosis or reversible myocardial depression? Intensive Care Med 2001; 27:959-961. (Pubitemid 32662474)
23. Parrillo JE. Pathogenetic mechanisms of septic shock. N Engl J Med 1993; 328:1471-1477.
24. Guzy PM. Creatine phosphokinase-MB (CPK-MB) and the diagnosis of myocardial infarction. West J Med 1977; 127:455-460. (Pubitemid 8267479)
25. Ingwall JS, Kramer MF, Fifer MA, et al. The creatine kinase system in normal and diseased human myocardium. N Engl J Med 1985; 313:1050-1054. (Pubitemid 16243332)
26. Roberts R. Where, oh where has the MB gone? N Engl J Med 1985; 313:1081-1083.
27. Apple FS, Quist HE, Doyle PJ, Otto AP, Murakami MM. Plasma 99th percentile reference limits for cardiac troponin and creatine kinase MB mass for use with European Society of Cardiology/American College of Cardiology consensus recommendations. Clin Chem 2003; 49:1331-1336. (Pubitemid 36900619)
28. Welsh TM, Kukes GD, Sandweiss LM. Differences of creatine kinase MB and cardiac troponin I concentrations in normal and diseased human myocardium. Ann Clin Lab Sci 2002; 32:44-49. (Pubitemid 34137432)
29. McErlean ES, Deluca SA, van Lente F, et al. Comparison of troponin T versus creatine kinase-MB in suspected acute coronary syndromes. Am J Cardiol 2000; 85:421-426. (Pubitemid 30089615)
30. Goodman SG, Steg PG, Eagle KA, et al. The diagnostic and prognostic impact of the redefinition of acute myocardial infarction: lessons from the Global Registry of Acute Coronary Events (GRACE). Am Heart J 2006; 151:654-660. (Pubitemid 43290256)
31. Kalayeh N. CK-MB has prognostic value independent of troponins in non-ST-elevation ACS population [abstract]. J Am Coll Cardiol 2010; 55:A118.E1104.
32. Lindsell CJ, Anantharaman V, Diercks D, et al. The Internet Tracking Registry of Acute Coronary Syndromes (i-trACS): a multicenter registry of patients with suspicion of acute coronary syndromes reported using the standardized reporting guidelines for emergency department chest pain studies. Ann Emerg Med 2006; 48:666-677; 677e1-677e9.
33. Ottani F, Galvani M, Nicolini FA, et al. Elevated cardiac troponin levels predict the risk of adverse outcome in patients with acute coronary syndromes. Am Heart J 2000; 140:917-927.
34. Rao SV, Ohman EM, Granger CB, et al. Prognostic value of isolated troponin elevation across the spectrum of chest pain syndromes. Am J Cardiol 2003; 91:936-940. (Pubitemid 36398524)
35. Morrow DA. Clinical application of sensitive troponin assays. N Engl J Med 2009; 361:913-915.
36. Januzzi JL Jr, Bamberg F, Lee H, et al. High-sensitivity troponin T concentrations in acute chest pain patients evaluated with cardiac computed tomography. Circulation 2010; 121:1227-1234.
37. Keller T, Zeller T, Peetz D, et al. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med 2009; 361:868-877.
38. Reichlin T, Hochholzer W, Bassetti S, et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med 2009; 361:858-867.
39. Giannitsis E, Becker M, Kurz K, Hess G, Zdunek D, Katus HA. Highsensitivity cardiac troponin T for early prediction of evolving non-STsegment elevation myocardial infarction in patients with suspected acute coronary syndrome and negative troponin results on admission. Clin Chem 2010; 56:642-650.
40. Apple FS, Pearce LA, Smith SW, Kaczmarek JM, Murakami MM. Role of monitoring changes in sensitive cardiac troponin I assay results for early diagnosis of myocardial infarction and prediction of risk of adverse events. Clin Chem 2009; 55:930-937.
41. Keller T, Tzikas S, Zeller T, et al. Copeptin improves early diagnosis of acute myocardial infarction. J Am Coll Cardiol 2010; 55:2096-2106.
42. Kanji J, Fan J. Discordant creatine kinase and cardiac troponin T in the workup of acute coronary syndrome. CJEM 2010; 12:64-68.